Opendata, web and dolomites

PUPILOSCOPE SIGNED

Pupiloscope, a Neuro-Critical Care Device, Enabling Quantitative, Real-Time, Pupillary Monitoring and Assessment of Patients with Neurotrauma and Head Injuries.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PUPILOSCOPE project word cloud

Explore the words cloud of the PUPILOSCOPE project. It provides you a very rough idea of what is the project "PUPILOSCOPE" about.

industry    sales    triage    manufacturing    opinion    pupiloscope    life    light    forecasts    doctors    markets    33    head    vivo    society    quantitative    levels    impacting    pupillary    alone    human    solution    launch    health    globally    injury    unmet    hospital    subjective    death    accurate    people    injuries    billion    direct    critical    patients    economics    potentially    neuro    successfully    young    proven    ready    paramedics    experts    time    breakthrough    device    suffer    estimate    clinical    medicating    brain    clinically    victims    reducing    traumatic    tbi    worldwide    leaders    prone    seek    prototype    threatening    secondary    eyes    relatives    annum    skill    patient    error    disability    positively    monitoring    validation    societal    reg    an    outcomes    engineers    emergency    approved    care    mild    global    healthcare    shining    trl    regulatory    finalisation    prevent    incorporating    nurses    approval    quick    functional    clinicians    42    medical    million    ce   

Project "PUPILOSCOPE" data sheet

The following table provides information about the project.

Coordinator
VIVO SMART MEDICAL DEVICES LTD 

Organization address
address: 6 EDISON VILLAGE NOTTINGHAM SCIENCE TECHNOLOGY PARK
city: NOTTINGHAM
postcode: NG7 2RF
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.pupiloscope.com
 Total cost 1˙250˙911 €
 EC max contribution 875˙637 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIVO SMART MEDICAL DEVICES LTD UK (NOTTINGHAM) coordinator 875˙637.00

Map

 Project objective

An estimated 42 million people Worldwide suffer a Head Injury (2.5 million in the EU) that can lead to Mild or Traumatic Brain Injury (TBI). It is a major cause of death and disability, especially in young people, impacting victims and relatives, with significant costs to society, estimated at €33 Billion per annum in Europe alone.

Pre-Hospital and Emergency Care Neuro-Monitoring, including pupillary assessment, is critical in the processes of triage, management and medicating patients to prevent secondary injury to the brain. However, the current method of shining a light into a patient's eyes, in order to estimate pupillary response, is subjective and prone to human error.

The solution is Pupiloscope®, enabling Accurate, Real-time, Quantitative Pupillary Monitoring and Assessment for patients with potentially life threatening head injuries. Pupiloscope is a breakthrough technology that will positively impact clinical pathways as well as patient outcomes. It is quick, simple, and easy to use by Doctors, Nurses and Paramedics of all skill levels. Through collaboration with industry experts, key opinion leaders, engineers and Emergency Care based clinicians, who identified the unmet clinical need, ViVO has successfully developed a functional prototype to TRL 6.

As a direct result of this project, Pupiloscope forecasts sales of €20 Million within 5 years of product launch, improving patient outcomes and reducing both the societal and costs of care in the EU and Globally by an estimated €2 Billion per annum.

This project will seek to develop Pupiloscope into a clinically proven, manufacturing ready and CE approved medical device; incorporating technology finalisation, regulatory approval, health economics, clinical testing and validation, therefore enabling product launch and sales to the EU and Global Emergency Care healthcare markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PUPILOSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PUPILOSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LTS (2020)

LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More